[{"orgOrder":0,"company":"University Medicine Greifswald","sponsor":"SDI Limited","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Potassium Iodide","moa":"||Immune","graph1":"Dental and Oral Health","graph2":"Phase II\/ Phase III","graph3":"University Medicine Greifswald","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Solution","sponsorNew":"University Medicine Greifswald \/ SDI Limited","highestDevelopmentStatusID":"9","companyTruncated":"University Medicine Greifswald \/ SDI Limited"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          University Medicine Greifswald

                          Country arrow
                          EPSC
                          Not Confirmed

                          University Medicine Greifswald

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          March 18, 2021

                          Lead Product(s) : Silver Fluoride,Potassium Iodide

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : SDI Limited

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank